WebExplore {Eikonizo Therapeutics's key management people. Discover current leadership team members including founders, CEO, other executives and board directors. Eikonizo … WebFeb 9, 2024 · About Eikonizo Therapeutics, Inc. Eikonizo is a privately-held biotechnology company developing life-changing therapies by creating brain-penetrant small molecules …
About Us – Eikonizo
WebMar 15, 2024 · Janice Kranz is the Chief Executive Officer & Co-Founder at Eikonizo Therapeutics based in North Cambridge, Massachusetts. Previously, Janice was the Consultant at Collaborative Drug Discovery and also held positions at Boston Millennia Partners, BIOBASE, Brandeis University, Cubist Pharmaceuticals, Beth Israel … WebFeb 18, 2024 · Eikonizo Therapeutics is a biotechnology company focused on the development of small molecules that are able to enter the brain and reach specific therapeutic targets. The company’s lead program is directed at neurodegenerative diseases and involves inhibiting specific enzymes called histone deacetylases (HDACs). red dawn was right
New research uncovers a path to lowering obesity in mice by …
WebFeb 9, 2024 · “Eikonizo is discovering and developing novel small molecule therapeutics and leveraging companion target engagement technology to de-risk and accelerate … WebEikonizo Therapeutics Jeff Jonker CEO Belharra Therapeutics Raul Oliva CEO & Co-Founder Sidekick Bio, Inc. Ty Howe Biotech advisor Marsh USA Florian Brand CEO & Co-Founder atai Life Sciences . Adel Nada CEO GentiBio Tess Cameron Principal RA Capital Rohan Palekar CEO 89bio Inc Daniel Bradbury WebEikonizo Therapeutics. Business Services · Massachusetts, United States · <25 Employees . Eikonizo is a privately-held biotechnology company developing life-changing therapies by creating brain-penetrant small molecules and deploying in vivo target engagement techniques to accelerate the identification of therapeutics. red dawn watch